Early effects predict trajectories of response to esketamine in treatment-resistant depression-Reference-Cited by-同舟云学术

Early effects predict trajectories of response to esketamine in treatment-resistant depression

Published:2023-12 Issue: Volume:342 Page:166-176
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Estrade Isaure,Petit Anne-Cécile,Sylvestre Vincent,Danon Michel,Leroy Sylvain,Perrain Rebecca,Vinckier Fabien,Mekaoui Lila,Gaillard Raphaël,Advenier-Iakovlev Emmanuelle,Mancusi Rossella Letizia,Poupon Daphnée,De Maricourt Pierre,Gorwood Philip

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference55 articles.

1. The antidepressant effect of ketamine is dampened by concomitant benzodiazepine medication;Andrashko;Front. Psych.,2020

2. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate;Anis;Br. J. Pharmacol.,1983

3. Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis;Bahji;Expert Opin. Drug Saf.,2022

4. Antidepressant effects of ketamine in depressed patients;Berman;Biol. Psychiatry,2000

5. Esketamine: a novel option for treatment-resistant depression;Bozymski;Ann. Pharmacother.,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and risks of esketamine nasal spray continuation in treatment-resistant depression;Biomarkers in Neuropsychiatry;2024-12

2. IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression;Psychiatry Research;2024-10

3. Efficacy of intravenous esketamine in reducing suicidal ideation and major depressive symptoms: A real-world evidence study;Journal of Affective Disorders Reports;2024-07

4. Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review;Frontiers in Psychiatry;2024-05-15

5. Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine;Neuroscience Letters;2024-05